Prognostic value of B-type natriuretic peptide in surgical palliation of children with single-ventricle congenital heart disease

Pediatric Cardiology

Volumn 29, Issue 1, 2008, Pages 70-75

  Berry, J G ^a   Askovich, B ^a,b   Shaddy, R E ^a,b   Hawkins, J A ^a,b   Cowley, C G ^a,b  

^a BOSTON CHILDREN S HOSPITAL   (United States)

^b UNIVERSITY OF UTAH HEALTH SCIENCES CENTER   (United States)

Author keywords

B type natriuretic peptide; Congenital heart disease; Single ventricle physiology; Surgery

Indexed keywords

BRAIN NATRIURETIC PEPTIDE;

ARTICLE; ARTIFICIAL VENTILATION; CAVOPULMONARY CONNECTION; CLINICAL ARTICLE; CLINICAL TRIAL; CONGENITAL HEART DISEASE; CONTROLLED STUDY; FONTAN PROCEDURE; HOSPITALIZATION; HUMAN; INTERMETHOD COMPARISON; PALLIATIVE THERAPY; PROGNOSIS;

CARDIOTONIC AGENTS; DOBUTAMINE; FEMALE; FONTAN PROCEDURE; HEART BYPASS, RIGHT; HEART DEFECTS, CONGENITAL; HEART VENTRICLES; HUMANS; INFANT; LENGTH OF STAY; MALE; MILRINONE; MULTIVARIATE ANALYSIS; NATRIURETIC PEPTIDE, BRAIN; PALLIATIVE CARE; POSTOPERATIVE PERIOD; PROGNOSIS; PROSPECTIVE STUDIES;

EID: 38349138493     PISSN: 01720643     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00246-007-9012-3     Document Type: Article

References (25)

1. Ationu A, Singer DR, Smith A, Elliott M, Burch M, Carter ND (1993) Studies of cardiopulmonary bypass in children: Implications for the regulation of brain natriuretic peptide. Cardiovasc Res 27:1538-1541
2. Ationu A, Sorensen K, Whitehead B, Singer D, Burch M, Carter ND (1993) Ventricular expression of brain natriuretic peptide gene following orthotopic cardiac transplantation in children - A three year follow up. Cardiovasc Res 27:2135-2139
3. Chen HH, Burnett JC Jr. (1999) The natriuretic peptides in heart failure: Diagnostic and therapeutic potentials. Proc Assoc Am Phys 111:406-416
4. Costello JM, Backer CL, Checchia PA, Mavroudis C, Seipelt RG, Goodman DM (2004) Alterations in the natriuretic hormone system related to cardiopulmonary bypass in infants with congestive heart failure. Pediatr Cardiol 25:347-353
5. Costello JM, Backer CL, Checchia PA, Mavroudis C, Seipelt RG, Goodman DM (2005) Effect of cardiopulmonary bypass and surgical intervention on the natriuretic hormone system in children. J Thorac Cardiovasc Surg 130:822-829
6. Cowley CG, Bradley JD, Shaddy RE (2004) B-type natriuretic peptide levels in congenital heart disease. Pediatr Cardiol 25:336-340
7. Cuthbertson BH, McKeown A, Croal BL, Mutch WJ, Hillis GS (2005) Utility of B-type natriuretic peptide in predicting the level of peri- and postoperative cardiovascular support required after coronary artery bypass grafting. Crit Care Med 33:437-442
8. Das SR, Drazner MH, Dries DL, Vega GL, Stanek HG, Abdullah SM, et al. (2005) Impact of body mass and body composition on circulating levels of natriuretic peptides: Results from the Dallas Heart Study. Circulation 112:2163-2168
9. Doust JA, Pietrzak E, Dobson A, Glasziou P (2005) How well does B-type natriuretic peptide predict death and cardiac events in patients with heart failure: Systematic review. Br Med J 330:625
10. Hutfless R, Kazanegra R, Madani M, Bhalla MA, Tulua-Tata A, Chen A, et al. (2004) Utility of B-type natriuretic peptide in predicting postoperative complications and outcomes in patients undergoing heart surgery. J Am Coll Cardiol 43:1873-1879
11. Kawamura T, Wago M, Kawaguchi H, Tahara M, Yuge M (2000) Plasma brain natriuretic peptide concentrations in patients with Kawasaki disease. Pediatr Int 42:241-248
12. Koch A, Singer H (2003) Normal values of B type natriuretic peptide in infants, children, and adolescents. Heart 89:875-878
13. Kragelund C, Gronning B, Kober L, Hildebrandt P, Steffensen R (2005) N-terminal pro-B-type natriuretic peptide and long-term mortality in stable coronary heart disease. N Engl J Med 352:666-675
14. Mair J, Friedl W, Thomas S, Puschendorf B (1999) Natriuretic peptides in assessment of left-ventricular dysfunction. Scand J Clin Lab Invest 230(Suppl):132-142
15. McCullough PA, Sandberg KR (2003) B-type natriuretic peptide and renal disease. Heart Fail Rev 8:355-358
16. Morita E, Yasue H, Yoshimura M, Ogawa H, Jougasaki M, Matsumura T, et al. (1993) Increased plasma levels of brain natriuretic peptide in patients with acute myocardial infarction. Circulation 88:82-91
17. Qi W, Mathisen P, Kjekshus J, Simonsen S, Bjornerheim R, Endresen K, et al. (2001) Natriuretic peptides in patients with aortic stenosis. Am Heart J 142:725-732
18. Shih CY, Sapru A, Oishi P, Azakie A, Karl TR, Harmon C, et al. (2006) Alterations in plasma B-type natriuretic peptide levels after repair of congenital heart defects: A potential perioperative marker. J Thorac Cardiovasc Surg 131:632-638
19. Stein BC, Levin RI (1998) Natriuretic peptides: Physiology, therapeutic potential, and risk stratification in ischemic heart disease. Am Heart J 135:914-923
20. Sun LS, Dominguez C, Mallavaram NA, Quaegebeur JM (2005) Dysfunction of atrial and B-type natriuretic peptides in congenital univentricular defects. J Thorac Cardiovasc Surg 129:1104-1110
21. Takemura G, Fujiwara H, Takatsu Y, Fujiwara T, Nakao K (1995) Ventricular expression of atrial and brain natriuretic peptides in patients with myocarditis. Int J Cardiol 52:213-222
22. Yamada Y, Goto J, Yokota M (1997) Brain natriuretic peptide is a sensitive indicator of impaired left-ventricular function in elderly patients with cardiovascular disease. Cardiology 88:401-407
23. Yildiz R, Yildirim B, Karincaoglu M, Harputluoglu M, Hilmioglu F (2005) Brain natriuretic peptide and severity of disease in non-alcoholic cirrhotic patients. J Gastroenterol Hepatol 20:1115-1120
24. Yoshimura N, Yamaguchi M, Oshima Y, Oka S, Ootaki Y, Hasegawa T, et al. (2000) Suppression of the secretion of atrial and brain natriuretic peptide after total cavopulmonary connection. J Thorac Cardiovasc Surg 120:764-769
25. Zhou L, Giacherio D, Cooling L, Davenport RD (2005) Use of B-natriuretic peptide as a diagnostic marker in the differential diagnosis of transfusion-associated circulatory overload. Transfusion 45:1056-1063